Evidence map›Paper›PMID 40453256›Full record

ArticleCureus2025

Demographic and Phenotypic Distribution of Inflammatory Bowel Disease in 1015 Patients Attending a Quaternary Care Center in Nepal.

Umid K Shrestha, Rabin Sharma

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Umid K ShresthaDepartment of Gastroenterology and Hepatology, Nepal Mediciti Hospital, Lalitpur, NPL.
Rabin SharmaDepartment of Gastroenterology and Hepatology, Nepal Mediciti Hospital, Lalitpur, NPL.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective Inflammatory bowel disease (IBD), comprising ulcerative colitis (UC) and Crohn's disease (CD), has been seen as an emerging health problem in Nepal with urbanization and the adoption of a Western lifestyle. Our study aimed to determine the various demographic and phenotypic features of IBD in Nepal. Methods This prospective observational study was conducted at the Nepal Mediciti Hospital (Lalitpur, NPL), comprising IBD patients from 2017 to 2024. The demographic distribution of IBD was classified according to age, gender, and ethnicity, while the phenotypic distribution was done according to disease location and severity of the disease. Results Among 1015 IBD patients, 752 (74.1%) had UC and 263 (25.9%) had CD. The IBD was predominantly seen in males (60.7% vs 39.3 %). The mean age at diagnosis of IBD was 39.67 ± 14.53 years, 38.3 ± 8.4 years for UC, and 31.8 ± 6.7 years for CD. Inflammatory bowel disease was more common (51.1%) in the Khas-Arya race, followed by Newars (18.8%). The most common location of UC was left-sided (43.8%), and ileocolonic for CD (55.5%). The majority of the IBD patients presented in a state of moderate activity (UC 50.1% and CD 62.4%), followed by mild activity (UC 39.2% and CD 29.3%). Only a few IBD patients presented in severe form (UC 10.6% and CD 8.4%). Conclusion This study highlights the increasing burden of IBD in Nepal, affecting more men than women, occurring at the mean age of thirties, and mostly seen in the Khas-Arya race. We found mostly left-sided disease in UC patients, while ileocolonic disease was the most common phenotype in CD. The majority of IBD patients in our study presented with moderate activity. Further large-scale, long-term, multi-center studies are needed to provide a more comprehensive knowledge of the clinico-epidemiological evaluation of IBD in Nepal.

Indexed as

agecrohn’s diseasedemographicdistributionethnicgenderinflammatory bowel diseasenepalphenotypiculcerative colitis

Identifiers

PMID40453256
PMCPMC12123162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.